Niaid preclinical development support - production of the mhrp GP145 clade c trimer protein
Ended Awarded Last action
- Contract number
- HHSN27200005
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $9,967,500
Award facts
- Contract value 100% obligated
- $9,967,500.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $25,135 | |
| Definitize Change Order | $254,278 | |
| Funding Only Action | $92,245 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $479,765 | |
| Funding Only Action | $67,221 | |
| Change Order | $998,870 | |
| Change Order | $741,858 | |
| Change Order | $375,478 | |
| Other Administrative Action | $0 | |
| Change Order | $1,136,533 | |
| Original award | $5,796,117 |
Show all 12
About this award
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL). The $9,967,500.00 cost-plus-fixed-fee contract supports NIAID's Preclinical Development program, specifically the production of the MHRP GP145 Clade C trimer protein. This contract does not have a set-aside designation. ABL, a for-profit manufacturer of goods, has been awarded numerous federal contracts and grants, particularly from NIAID and other NIH institutes, to advance the development of medical countermeasures for various infectious diseases. The company provides a wide range of preclinical and clinical development services, including cGMP manufacturing, process development, analytical testing, and project management support for infectious disease programs.
Quick answers
Who was awarded contract HHSN27200005?
HHSN27200005 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 27, 2012.
How much is contract HHSN27200005 worth?
The government has obligated $9,967,500 on HHSN27200005.
Is contract HHSN27200005 an order under another contract?
Yes. HHSN27200005 is a delivery order under HHSN272201100021I, an indefinite delivery contract.
Was contract HHSN27200005 competed?
The extent of competition for HHSN27200005 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award